---
figid: PMC3229969__aging-03-920-g002
figlink: /pmc/articles/PMC3229969/figure/F2/
number: Figure 2
caption: A) FGFRs possess three extracellular immunoglobulin-like domains (Ig I to
  III), a transmembrane domain (TM) and an intracellular protein tyrosine kinase domain
  (PTK).The third Ig-like domain (III) is thought to confer ligand specificity. The
  C-terminal half of this IgIII domain (dotted line) is alternatively encoded by either
  exon 8 or 9 of the receptor gene, which create the two main isoforms of FGFR1, 2
  and 3 (IIIb for exon 8 and IIIc for exon 9). Other isoforms also exist (no PTK domain,
  no TM domain) but are less abundant. B) Creation of the ternary complex between
  heparan sulfate proteoglycans (HSPGs), FGF ligands, and FGFRs leads to autophosphorylation
  of the PTK domains and activation of a number of intracellular pathways downstream.
  FRS2 and Grb2 and the main mediators of the signaling and activate various effectors
  such as PI3K/AKT and MAPKs. Other pathways (Shp2, PLC-γ) are also activated. Note
  that activation of the PI3K pathway can lead to phosphorylation of MDM2 on Ser186,
  leading to its translocation to the nucleus and subsequent degradation of p53.
pmcid: PMC3229969
papertitle: Roles of FGF signaling in stem cell self-renewal, senescence and aging.
reftext: Daniel L. Coutu, et al. Aging (Albany NY). 2011 Oct;3(10):920-933.
pmc_ranked_result_index: '112405'
pathway_score: 0.8165945
filename: aging-03-920-g002.jpg
figtitle: Roles of FGF signaling in stem cell self-renewal, senescence and aging
year: '2011'
organisms: Homo sapiens
ndex: c86b5720-dea1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3229969__aging-03-920-g002.html
  '@type': Dataset
  description: A) FGFRs possess three extracellular immunoglobulin-like domains (Ig
    I to III), a transmembrane domain (TM) and an intracellular protein tyrosine kinase
    domain (PTK).The third Ig-like domain (III) is thought to confer ligand specificity.
    The C-terminal half of this IgIII domain (dotted line) is alternatively encoded
    by either exon 8 or 9 of the receptor gene, which create the two main isoforms
    of FGFR1, 2 and 3 (IIIb for exon 8 and IIIc for exon 9). Other isoforms also exist
    (no PTK domain, no TM domain) but are less abundant. B) Creation of the ternary
    complex between heparan sulfate proteoglycans (HSPGs), FGF ligands, and FGFRs
    leads to autophosphorylation of the PTK domains and activation of a number of
    intracellular pathways downstream. FRS2 and Grb2 and the main mediators of the
    signaling and activate various effectors such as PI3K/AKT and MAPKs. Other pathways
    (Shp2, PLC-γ) are also activated. Note that activation of the PI3K pathway can
    lead to phosphorylation of MDM2 on Ser186, leading to its translocation to the
    nucleus and subsequent degradation of p53.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K7
  - MAPK13
  - MAP2K3
  - MAP2K6
  - MAPK9
  - PRKCD
  - KRAS
  - SOS2
  - PRKCB
  - MAP2K5
  - FRS2
  - MAPK10
  - PTPN11
  - HRAS
  - PTK2B
  - NRAS
  - PRKCA
  - BRAF
  - AKT1
  - SOS1
  - MAPK1
  - PRKCE
  - MAPK11
  - PRKCZ
  - SHC3
  - MAPK14
  - ARAF
  - AKT3
  - MAPK8
  - AKT2
  - SHC1
  - MAPK3
  - SHC4
  - PRKD3
  - MAP2K4
  - PRKCQ
  - MDM2
  - PRKCG
  - RAF1
  - PRKCH
  - PDK1
  - MAPK12
  - PRKCI
  - GAB1
  - SHC2
  - TP53
  - GRB2
  - Cancer
  - Noonan syndrome
genes:
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K7
  entrez: '5609'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K3
  entrez: '5606'
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K6
  entrez: '5608'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PKC-
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: PKC-
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K5
  entrez: '5607'
- word: FRS2
  symbol: FRS2
  source: hgnc_symbol
  hgnc_symbol: FRS2
  entrez: '10818'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: Shp2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PTK
  symbol: PTK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2B
  entrez: '2185'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PKC-
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKC-
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PKC-
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: PKC-
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K4
  entrez: '6416'
- word: PKC-
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: PKC-
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PKC-
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PKC-
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: Gab1
  symbol: GAB1
  source: hgnc_symbol
  hgnc_symbol: GAB1
  entrez: '2549'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: '`Grb2'
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
